| Financial Year |
March 31 2023 |
| Monetary Funds |
43,501,364.85 |
| Held-for-trading Financial Assets |
127,000,000.00 |
| Notes Receivable |
11,895,464.09 |
| Accounts Receivable |
122,070,035.20 |
| Advances to Suppliers |
9,076,039.03 |
| Other Receivables |
9,986,428.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
68,062,416.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,812,315.23 |
| Total Current Assets |
400,705,725.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,917,203.04 |
| Investment Properties |
-- |
| Fixed Assetes |
130,869,673.21 |
| Under-construction Projects |
44,711,749.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,892,440.86 |
| R&D expenses |
-- |
| Goodwill |
53,241,371.42 |
| Long-Term Deferred and Prepaid Expenses |
21,796,345.10 |
| Deferred Income Tax Assets |
23,897,679.65 |
| Other Non-Current Assets |
301,600.00 |
| Sub-Total of Non-Current Assets |
425,419,472.42 |
| Total Assets |
826,125,197.49 |
| Short-Term Loans |
29,300,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
24,308,509.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,924,106.86 |
| Taxes Payable |
5,513,820.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,071,169.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,600,077.45 |
| Other Current Liabilities |
789,062.14 |
| Sub-Total of Current Liabilities |
102,646,384.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
293,151.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,866,415.95 |
| Total Liabilities |
138,512,800.30 |
| Paid-In Capital(Or Share Stock) |
126,048,000.00 |
| Capital Surplus |
329,905,485.79 |
| Surplus Reserve |
41,523,430.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
189,319,020.01 |
| Minority Stockholder's Interest |
816,461.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
686,795,935.87 |
| Owner's Equity（Stockholder's Equity） |
687,612,397.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
826,125,197.49 |
